Adalid Sciences
Biotechnology Research
Advanced drug delivery systems for genomic medicine, utilizing innovative lipid nanoparticles (LNPs).
About us
At Adalid, we are dedicated to advancing pharmaceutical solutions through the development of novel lipid nanoparticle technology. By leveraging LNPs, we aim to enhance the stability and bioavailability of drugs, improving their therapeutic efficacy while minimizing potential side effects. Our team has accumulated decades of expertise in using lipid nanoparticles as a delivery system for nucleic acids and related fields. With our strong background in synthetic chemistry, biochemistry, and nanoparticle formulation, we can provide added value and seamlessly integrate into our clients' workflows.
- Website
-
www.adalidsciences.com
External link for Adalid Sciences
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Type
- Public Company
- Founded
- 2024
- Specialties
- Biotechnology, Lipid Nanoparaticles, LNP, Drug Delvery Systems, Synthetic Chemistry, Preclinical Characterization, Research Management, Pharmaceuticals, Protein Replacement Therapies, Monoclonal Antibodies, Vaccines, RNA Therapeutics, and Gene Editing Technologies
Employees at Adalid Sciences
-
David Schreib
Embracing complexity, aspiring simplicity, making things happen...
-
Radim Pilous
Versatile and innovative executive and businessman. Industry - Heathcare - SaaS. Global - Local - Glocal.
-
Klara Grantz Saskova
Adalid Sciences - Nanotechnology For Gene Delivery
-
Bedřich Formánek
R&D Chemist